XBiotech's market cap is currently ―. The company's EPS TTM is $-1.083; its P/E ratio is -3.16; XBiotech is scheduled to report earnings on May 9, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 300.00K	$ 1.68M	$ 1.53M	$ 500.00K	$ 4.50M
Gross Profit	$ 284.00K	$ 1.47M	$ 1.32M	$ 287.00K	$ 3.45M
EBIT	$ -8.16M	$ -6.39M	$ -12.09M	$ -7.84M	$ -7.19M
EBITDA	$ -7.72M	$ -5.66M	$ -11.37M	$ -7.13M	$ -6.49M
Net Income Common Stockholders	$ -3.20M	$ -12.66M	$ -11.64M	$ -5.39M	$ -6.47M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 217.48M	$ 220.10M	$ 225.79M	$ 231.82M	$ 236.98M
Total Assets	$ 246.10M	$ 250.83M	$ 266.46M	$ 270.80M	$ 275.18M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -217.48M	$ -220.10M	$ -225.79M	$ -231.82M	$ -236.98M
Total Liabilities	$ 5.70M	$ 6.03M	$ 10.67M	$ 5.24M	$ 5.79M
Stockholders Equity	$ 240.40M	$ 244.81M	$ 255.79M	$ 265.56M	$ 269.38M
Cash Flow	-
Free Cash Flow	$ 2.57M	$ -6.24M	$ -6.46M	$ -5.28M	$ -2.23M
Operating Cash Flow	$ 2.70M	$ -6.03M	$ -6.38M	$ -5.12M	$ -1.76M
Investing Cash Flow	$ -3.91M	$ -59.74M	$ -82.00K	$ -161.00K	$ -476.00K
Financing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 33.00K

Currency in USD

XBiotech Earnings and Revenue History

Income Statement >

XBiotech Debt to Assets

Balance Sheet >

XBiotech Cash Flow

Cash Flow >

XBiotech Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing